NCT05018832View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Traumatic Brain Injury
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (1)

Unknown

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER